市场调查报告书
商品编码
1547519
全球放射性皮肤炎市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Radiation Dermatitis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球放射性皮肤炎市场需求预计将从 2023 年的 5.0241 亿美元达到 2032 年的近 8.1693 亿美元,2024-2032 年研究期间复合年增长率为 5.55%。
放射性皮肤炎、放射性皮肤炎或X射线皮肤炎是癌症肿瘤放射治疗的外束电离辐射引起的皮肤损伤或放射性烧伤。它也可能很少由介入手术(例如栓塞手术、冠状动脉造影和留置导管置入)期间暴露于辐射引起。放射性皮肤炎主要采用外用药物治疗,如皮质类固醇、外用抗生素、亲水性乳膏、口服药物如口服皮质类固醇、口服止痛药、抗发炎药、抗生素和敷料。
越来越多的手术,包括放射治疗、栓塞手术、冠状动脉造影和留置导管放置,导致放射性皮肤炎盛行率增加。癌症负担的不断增加以及调强放射治疗等放射治疗技术的进步正在推动全球放射性皮肤炎市场的发展。放射治疗是放射性皮肤炎发生率上升的主要原因。放射治疗仍然是癌症治疗的重要组成部分,近 50% 的癌症患者在治疗期间的某个时刻接受放射治疗。减少放射治疗相关副作用的努力预计将为预测时间内的市场扩张提供利润丰厚的机会。然而,缺乏认识以及与放射性皮肤炎治疗相关的高成本预计将限制市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球放射性皮肤炎市场的每个细分市场进行了包容性评估。放射性皮肤炎产业的成长和趋势为本研究提供了整体方法。
放射性皮肤炎市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲放射性皮肤炎市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。放射性皮肤炎市场的主要参与者包括 3M 公司、MeInlycke Health Care AB、Smith & Nephew Plc、Integra Lifesciences Holdings Corporation、Intermed SA、ConvaTec Group Plc、BMG Pharma SPA 本节包括竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Radiation Dermatitis Market is presumed to reach the market size of nearly USD 816.93 Million by 2032 from USD 502.41 Million in 2023 with a CAGR of 5.55% under the study period 2024-2032.
Radiation dermatitis, radiodermatitis, or x-ray dermatitis is skin damage or a radiation burn caused by external beam ionizing radiation of radiotherapy for cancer tumors. It may also rarely result from exposure to radiation during interventional procedures such as embolization procedures, coronary angiography, and indwelling catheter placements. Radiation dermatitis is primarily treated with topical agents such as corticosteroids, topical antibiotics, hydrophilic creams, oral medications like oral corticosteroids, oral analgesics, anti-inflammatory agents, antibiotics, and dressings.
A rising number of procedures, including radiotherapy, embolization procedures, coronary angiography, and indwelling catheter placements, are responsible for increasing radiation dermatitis prevalence. The escalating burden of cancer and advances in radiation delivery technology, such as intensity-modulated radiation therapy, is driving the global radiation dermatitis market. Radiotherapy is majorly contributing to the rising radiation dermatitis incidences. Radiation therapy remains an essential component of cancer treatment, with nearly 50% of cancer patients receiving radiation therapy at some point during their treatment. Rising effort towards reducing side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast timeframe. However, lack of awareness and the high cost associated with radio dermatitis treatment is anticipated to restrict the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Radiation Dermatitis. The growth and trends of Radiation Dermatitis industry provide a holistic approach to this study.
This section of the Radiation Dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Radiation Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiation Dermatitis market include 3M Company, MeInlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A, ConvaTec Group Plc, BMG Pharma S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.